Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 37.17 is 72% above its 3-year average of 21.63, around the middle of its 3-year range (0.00–58.92).
As of the fiscal period ended Tuesday, June 30, 2026. 18.95% above its 12-month average of 31.25.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 37.17.
CURRENT RATIO
37.17
CURRENT RATIO AVG TTM
31.25
CURRENT RATIO AVG 3Y
27.34
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+18.95%
CURRENT VS 3Y AVG
+35.97%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.10
median of 445 covered companies
CURRENT VS SECTOR MEDIAN
+1099.07%
vs the sector median at left
Contineum Therapeutics, Inc.
Market Cap
$478.54M
Current Ratio
37.17
TTM Avg
31.25
3Y Avg
27.34
5Y Avg
N/A
Market Cap
$487.30M
Current Ratio
121.97
TTM Avg
23.71
3Y Avg
19.95
5Y Avg
19.50
Market Cap
$453.70M
Current Ratio
6.72
TTM Avg
10.04
3Y Avg
13.74
5Y Avg
16.43
Market Cap
$450.64M
Current Ratio
13.99
TTM Avg
3.82
3Y Avg
4.25
5Y Avg
5.96
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Contineum Therapeutics, Inc. (CTNM) | $478.54M | 37.17 | 31.25 | 27.34 | N/A |
| Arvinas, Inc. (ARVN)vs › | $481.33M | 7.91 | 4.78 | 4.69 | 6.49 |
| Cerus Corporation (CERS)vs › | $471.57M | 1.83 | 2.06 | 1.93 | 2.19 |
| Bright Minds Biosciences Inc. (DRUG)vs › | $487.30M | 121.97 | 23.71 | 19.95 | 19.50 |
| NRC Health (NRC)vs › | $468.31M | 0.65 | 0.55 | 0.77 | 1.10 |
| NeoGenomics, Inc. (NEO)vs › | $491.55M | 3.60 | 3.12 | 4.79 | 5.52 |
| Evolus, Inc. (EOLS)vs › | $491.93M | 1.70 | 2.15 | 2.20 | 2.10 |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $453.70M | 6.72 | 10.04 | 13.74 | 16.43 |
| Assembly Biosciences, Inc. (ASMB)vs › | $450.64M | 13.99 | 3.82 | 4.25 | 5.96 |
| Capricor Therapeutics, Inc. (CAPR)vs › | $447.43M | 7.35 | 8.39 | 5.06 | 6.73 |
Current Ratio
37.17
Quick Ratio
37.17
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 37.17 |
| 2026-03-31 | 38.00 |
| 2025-12-31 | 27.50 |
| 2025-09-30 | 29.07 |
| 2025-06-30 | 24.51 |
| 2025-03-31 | 21.47 |
| 2024-12-31 | 20.69 |
| 2024-09-30 | 37.06 |
| 2024-06-30 | 58.92 |
| 2024-03-31 | 19.20 |
| 2023-12-31 | 23.29 |
| 2023-09-30 | 18.50 |
| 2023-06-30 | 0.00 |
| 2023-03-31 | 0.00 |
| 2022-12-31 | 6.41 |
